In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...